Once-weekly bortezomib as the standard of care in multiple myeloma: results from an international survey of physicians.

ABSTRACT:

SUBMITTER: Banerjee R 

PROVIDER: S-EPMC10625982 | biostudies-literature | 2023 Nov

REPOSITORIES: biostudies-literature